Need an appointment today?
Some test options are ‘result ready’ in as little as 3 Working Days *
Gender Determination is available for all NIPT Tests.
In-depth screening from fetal DNA can analyse multiple genes for mutations causing severe genetic disorders in pregnancy.
Everyone has their own personal reason for performing NIPT. For some, it is because they do not know their biological family or there may be a history of genetic disease within the family. For other parents it may be due to a history of recurrent miscarriage or general pregnancy worries, and for many women it is done purely for reassurance purposes. Whatever the reason we are sensitive to the situation.
A NIPT test is performed using a simple blood test from the mother with no risk to your unborn baby in comparison to one of the ‘next step’ diagnostic tests such as Amniocentesis or Chorionic Villus Sampling. Each test is performed using a simple maternal blood sample at one of our recommended clinics or at home.
If you are unsure which test is most suitable for you you can contact us.
We provide unparalleled support to our customers and offer NIPT tests that range from a basic level screen, to karyotype level screening for rare autosomal abnormalities, microdeletion syndromes and in-depth genetic screening options for both parents from just 10 weeks of pregnancy.
Prenatal safe complete plus gives a more complete picture of the pregnancy risk for several clinically significant and life-altering genetic disorders, that are both inherited and de novo single-gene disorders.
While some parents consider a gender check at 14 weeks using an ultrasound, this method can be limited by baby’s position and image clarity. In comparison, NIPT uses a simple maternal blood sample to analyse fetal DNA, allowing gender determination alongside chromosomal screening with no risk to the baby.
This test provides analysis of chromosomes 13, 18, 21. This test is suitable for single and *twin pregnancies
*Only the presence or absence of the Y chromosome can be reported in twins.
This test provides analysis of chromosomes 13, 18, 21 and includes analysis of the X and Y sex chromosomes. This test is suitable for single and *twin pregnancies
*Only the presence or absence of the Y chromosome can be reported in twins.
Karyo gives you valuable information about the chromosomal status of the growing baby and screens all 24 chromosomes for the most common conditions, this includes analysis of chromosomes 9 and 16 which are known to cause intellectual and physical abnormalities and miscarriage.
Newer tests take advantage of next-generation sequencing (NGS) to bring a Whole Genome Sequencing (WGS) approach to NIPT, expanding test options beyond chromosomes 21, 18, and 13 to include rare autosomal aneuploidies (RAAs), sex chromosome aneuploidies (SCAs) and partial deletions and duplications. This test is suitable for single and *twin pregnancies.
*Only the presence or absence of the Y chromosome can be reported in twins.
This Test includes Inherited and Non-Inherited (De Novo) features that can identify conditions which may have otherwise gone undetected until after birth. Many disorders tested for are not typically associated with abnormal ultrasound findings (especially in the first trimester) or may not be evident until the late second or third trimester, when diagnostic invasive testing can pose a risk of preterm birth, or after delivery.
Inherited gene disorders include;
Cystic Fibrosis
Deafness autosomal recessive type 1A
Deafness autosomal recessive type 1B
Thalassemia-Beta
Sickle cell anaemia
Family history may not be a good indicator of risk for these conditions, which are commonly caused by Non- Inherited (De Novo) genetic mutations in 25 genes screens for 44 different genetic disorders. These include Syndromic disorders, Noonan syndromes, Skeletal disorders and Craniosynostosis syndromes. The five Mutations in these 25 genes cause skeletal dysplasia, congenital heart defects, multiple congenital malformation syndromes, multiple congenital anomalies, autism, epilepsy, and intellectual disability. This test Includes analysis of all 24 chromosomes for abnormalities above 7 MB across the fetal genome for the most common conditions and rarer Trisomy’s 1-22. This test includes chromosomal deletions and duplications for clinically significant syndromes including Cri-du-chat Syndrome, Prader-Willi Syndrome, Angelman Syndrome, 1p36 Deletion Syndrome and Wolf Hirschhorn Syndrome, and detects microdeletion syndromes. Offering a genetic screen in 4 genes for 5 inherited conditions including Cystic Fibrosis CFTR, Beta Thalassemia HBB, Sickle Cell Anaemia HBB, Autosomnal Recessive Deafness Type 1 A and 1b. Taken from 10 weeks it is suitable for single and *twin pregnancies, Gender determination is available.



4D HD Live ultrasound scans are a great way to obtain a clear, moving 3D image of your baby.
Learn More
There are rare occasions where circumstances outside of our control can affect waiting times for laboratory reports and where results may be delayed or even need to be repeated.
Results are provided after laboratory analysis and wait times are given to you in ‘working’ days i.e. Monday to Friday. They do not include weekends or public holidays within the UK or EU.
The wait time begins after a sample has reached the processing laboratory, not from first day of transport.
Please remember, these are highly advanced medical tests, therefore the length of analysis is dependent on how your blood sample behaves under laboratory conditions.
Results cannot be accelerated or partially given in any circumstance.
In very rare circumstances where there is not enough cfDNA (from baby) in maternal blood, the sample may need to be repeated and analysed further.
If you are unsure which test is most suitable for you you can contact us. We offer unparalleled support to our customers.
We use cookies to optimize our website and our service.